These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 10561699

  • 1. Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations.
    Gutmann DH, Haipek CA, Hoang Lu K.
    J Neurosci Res; 1999 Dec 01; 58(5):706-16. PubMed ID: 10561699
    [Abstract] [Full Text] [Related]

  • 2. Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression.
    Rong R, Surace EI, Haipek CA, Gutmann DH, Ye K.
    Oncogene; 2004 Nov 04; 23(52):8447-54. PubMed ID: 15378014
    [Abstract] [Full Text] [Related]

  • 3. [Neurofibromatosis type 2 (NF2)].
    Araki N, Takeshima H, Saya H.
    Gan To Kagaku Ryoho; 1997 Sep 04; 24(11):1427-31. PubMed ID: 9309136
    [Abstract] [Full Text] [Related]

  • 4. Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration.
    Chen Y, Gutmann DH, Haipek CA, Martinsen BJ, Bronner-Fraser M, Krull CE.
    Dev Dyn; 2004 Mar 04; 229(3):541-54. PubMed ID: 14991710
    [Abstract] [Full Text] [Related]

  • 5. Effects of Nf2 missense mutations on schwannomin interactions.
    Scoles DR, Chen M, Pulst SM.
    Biochem Biophys Res Commun; 2002 Jan 11; 290(1):366-74. PubMed ID: 11779178
    [Abstract] [Full Text] [Related]

  • 6. Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation.
    Tang X, Jang SW, Wang X, Liu Z, Bahr SM, Sun SY, Brat D, Gutmann DH, Ye K.
    Nat Cell Biol; 2007 Oct 11; 9(10):1199-207. PubMed ID: 17891137
    [Abstract] [Full Text] [Related]

  • 7. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
    Sherman L, Xu HM, Geist RT, Saporito-Irwin S, Howells N, Ponta H, Herrlich P, Gutmann DH.
    Oncogene; 1997 Nov 13; 15(20):2505-9. PubMed ID: 9395247
    [Abstract] [Full Text] [Related]

  • 8. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
    Surace EI, Haipek CA, Gutmann DH.
    Oncogene; 2004 Jan 15; 23(2):580-7. PubMed ID: 14724586
    [Abstract] [Full Text] [Related]

  • 9. The tumour suppressor protein NF2/merlin: the puzzle continues.
    Hovens CM, Kaye AH.
    J Clin Neurosci; 2001 Jan 15; 8(1):4-7. PubMed ID: 11148074
    [Abstract] [Full Text] [Related]

  • 10. The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton.
    Muranen T, Grönholm M, Lampin A, Lallemand D, Zhao F, Giovannini M, Carpén O.
    Hum Mol Genet; 2007 Jul 15; 16(14):1742-51. PubMed ID: 17566081
    [Abstract] [Full Text] [Related]

  • 11. Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin.
    Yamauchi J, Miyamoto Y, Kusakawa S, Torii T, Mizutani R, Sanbe A, Nakajima H, Kiyokawa N, Tanoue A.
    Exp Cell Res; 2008 Jul 01; 314(11-12):2279-88. PubMed ID: 18486129
    [Abstract] [Full Text] [Related]

  • 12. MAP, a protein interacting with a tumor suppressor, merlin, through the run domain.
    Lee IK, Kim KS, Kim H, Lee JY, Ryu CH, Chun HJ, Lee KU, Lim Y, Kim YH, Huh PW, Lee KH, Han SI, Jun TY, Rha HK.
    Biochem Biophys Res Commun; 2004 Dec 17; 325(3):774-83. PubMed ID: 15541357
    [Abstract] [Full Text] [Related]

  • 13. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
    Koga H, Araki N, Takeshima H, Nishi T, Hirota T, Kimura Y, Nakao M, Saya H.
    Oncogene; 1998 Aug 20; 17(7):801-10. PubMed ID: 9779996
    [Abstract] [Full Text] [Related]

  • 14. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ, Surace EI, Cambell M, Higgins RJ, Leutenegger CM, Bollen AW, LeCouteur RA, Gutmann DH.
    Vet Pathol; 2009 Sep 20; 46(5):884-92. PubMed ID: 19429976
    [Abstract] [Full Text] [Related]

  • 15. Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin.
    Schmucker B, Ballhausen WG, Kressel M.
    Eur J Cell Biol; 1997 Jan 20; 72(1):46-53. PubMed ID: 9013725
    [Abstract] [Full Text] [Related]

  • 16. NF2: the wizardry of merlin.
    Xiao GH, Chernoff J, Testa JR.
    Genes Chromosomes Cancer; 2003 Dec 20; 38(4):389-99. PubMed ID: 14566860
    [Abstract] [Full Text] [Related]

  • 17. Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.
    Shaw RJ, McClatchey AI, Jacks T.
    Cell Growth Differ; 1998 Apr 20; 9(4):287-96. PubMed ID: 9563848
    [Abstract] [Full Text] [Related]

  • 18. Merlin, the neurofibromatosis type 2 gene product, and beta1 integrin associate in isolated and differentiating Schwann cells.
    Obremski VJ, Hall AM, Fernandez-Valle C.
    J Neurobiol; 1998 Dec 20; 37(4):487-501. PubMed ID: 9858254
    [Abstract] [Full Text] [Related]

  • 19. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
    Golovnina K, Blinov A, Akhmametyeva EM, Omelyanchuk LV, Chang LS.
    BMC Evol Biol; 2005 Dec 02; 5():69. PubMed ID: 16324214
    [Abstract] [Full Text] [Related]

  • 20. The merlin tumor suppressor interacts with Ral guanine nucleotide dissociation stimulator and inhibits its activity.
    Ryu CH, Kim SW, Lee KH, Lee JY, Kim H, Lee WK, Choi BH, Lim Y, Kim YH, Lee KH, Hwang TK, Jun TY, Rha HK.
    Oncogene; 2005 Aug 11; 24(34):5355-64. PubMed ID: 16007223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.